| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 12/27/2006 | EP1242401B1 Cytotoxic agents comprising taxanes and their therapeutic use |
| 12/27/2006 | EP1021410B1 Prostaglandin agonists and their use to treat bone disorders |
| 12/27/2006 | CN1886403A Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas |
| 12/27/2006 | CN1886399A 喹唑啉衍生物 Quinazoline derivatives |
| 12/27/2006 | CN1886397A 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3) |
| 12/27/2006 | CN1886386A Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 12/27/2006 | CN1886381A Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
| 12/27/2006 | CN1886378A 1,4-disubstituted isoquinilone derivatives as RAF-kinase inhibitors useful for the treatment of proliferative diseases |
| 12/27/2006 | CN1886376A Pyridine compounds as inhibitors of dipeptidyl peptidase iv |
| 12/27/2006 | CN1886133A Indole compounds |
| 12/27/2006 | CN1884267A N-carboxylic acid derivative substituted benzooxazine compounds with herbicidal activity |
| 12/27/2006 | CN1291985C Neurotrophin production/secretion promoting agent |
| 12/27/2006 | CN1291983C Luminescent element material and luminescent element comprising the same |
| 12/27/2006 | CN1291975C New mandelic acid derivatives and their use as thrombase inhibitors |
| 12/26/2006 | US7153971 Contacting a carbohydrate with an amine to produce amino tetrahydroxy carbohydrate, protecting two hydroxy groups of tetrahydroxy carbohydrate, forming hydroxy heterocyclic-spiro moiety by reacting with activated carbonate, oxidizing OH |
| 12/26/2006 | US7153968 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease, eosinophilic granuloma, psoriasis and other benign or malignant proliferative skin diseases, endotoxic shock, laminitis in horses, colic in horses, septic shock, ulcerative colitis, Crohn's disease, reperfusion injury |
| 12/26/2006 | US7153964 Pyrimidine compounds |
| 12/26/2006 | US7153960 Synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 12/26/2006 | US7153959 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
| 12/26/2006 | US7153958 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 12/26/2006 | US7153889 Alzheimer's disease; antihistamines; attention deficit disorders; hyperactivity; bipolar disorders; cognition activators; psychological disorders; anticancer agents; antidepressants; antiepileptic agents; gastrointestinal disorders ; analgesics |
| 12/26/2006 | US7153883 Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds |
| 12/26/2006 | US7153880 Substituted diphenyl heterocycles useful for treating HCV infection |
| 12/26/2006 | US7153878 Substituted thiazoles and oxazoles, e.g., 4-{1-[4-[2-(2-Chloro-6-fluoro-phenyl)-ethyl]-2-(4-trifluoromethyl-phenyl)-thiazol-5-yl]-ethylsulfanyl}-2-methyl-phenoxy)-acetic acid; treating atherosclerosis and diabetes and creating Syndrome X |
| 12/26/2006 | US7153874 For therapy and prophylaxis of of disorders mediated in full or in part by metabotropic glutamate receptor 5, including, e.g. acute, traumatic and chronic degenerative processes of the nervous system, such as Alzheimer's disease, senile dementia, Parkinson's disease, Huntington's chorea |
| 12/26/2006 | US7153872 Cancer and fibrotic diseases |
| 12/26/2006 | US7153853 Heterocyclic compounds and antitumor drugs containing the same as the active ingredient |
| 12/26/2006 | US7153852 Skin disorders; antiinflammatory agents; brain disorders; chronic obstructive pulmonary disease; antiarthritic agents; inflammatory bowel disorders |
| 12/26/2006 | US7153848 13-C5-7-cycloalkylindolo[2.1-a][2]benzazepine derivatives; e.g., 3-[3-[3-[1-[[(13-cyclohexyl-7H-indolo[2,1-a][2]benzazepin-10-yl)carbonyl]amino]cyclopentyl]-1,2,4-oxadiazol-5-yl]phenyl]-(2E)-2-propenoic acid |
| 12/26/2006 | US7153815 Insecticide containing hydrazone derivative as the active ingredient and novel hydrazone derivative |
| 12/21/2006 | WO2006135828A2 Trisubstituted amines as phosphodiesterase 4 inhibitors |
| 12/21/2006 | WO2006135826A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/21/2006 | WO2006135721A1 Alkylquinoline and alkylquinazoline kinase modulators |
| 12/21/2006 | WO2006135646A1 Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators and related methods of synthesis |
| 12/21/2006 | WO2006135312A1 Trombin inhibiting 2,4-dioxo-3,4-dihydropyrimidine derivatives |
| 12/21/2006 | WO2006134955A1 1, 2-di(cyclic group)substituted benzene derivative |
| 12/21/2006 | WO2006134481A1 Inhibitors of 11-beta hydroxysteroid dehydrogenase type 1 |
| 12/21/2006 | WO2006134468A1 Substituted arylpyrazoles for use against parasitites |
| 12/21/2006 | WO2006134466A1 Substituted arylpyrazoles as parasiticidal agents |
| 12/21/2006 | WO2006134382A1 N-(2, 2-dimethylpropyl) -6- (3-fluoro-5- ( (3-isoxazolylamino) carbonyl) -2-methylpheny l) -3-pyridinecarboxamide |
| 12/21/2006 | WO2006134378A1 Compounds for the treatment of multi-drug resistant bacterial infections |
| 12/21/2006 | WO2006134317A1 Oxadiazole derivatives as dgat inhibitors |
| 12/21/2006 | WO2006134163A2 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 12/21/2006 | WO2006133946A1 Azab i cyclo [3 . 1 . 0] hexane derivatives as dopamin d3 receptor modulators |
| 12/21/2006 | WO2006133926A1 Pyrazole derivates as cannabinoid receptor modulators |
| 12/21/2006 | WO2006133567A1 Helix 12 directed non-steroidal antiandrogens |
| 12/21/2006 | WO2006092599A3 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |
| 12/21/2006 | WO2006021420A3 Method for the production of diarylcycloalkyl derivatives |
| 12/21/2006 | WO2005110994A8 Substituted pyrazolyl urea derivatives useful in the treatment of cancer |
| 12/21/2006 | WO2005092856A8 Tetrahydrocarbazoles and derivatives |
| 12/21/2006 | WO2005047244A3 Inhibition of fgfr3 and treatment of multiple myeloma |
| 12/21/2006 | US20060287536 Phenyl-thiophene type vitamin d receptor modulators |
| 12/21/2006 | US20060287534 Method of obtaining urethane-protected n-carboxyanhydrides of alpha amino acids |
| 12/21/2006 | US20060287532 Regiospecific Synthesis of Nicotine Derivatives |
| 12/21/2006 | US20060287387 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders |
| 12/21/2006 | US20060287379 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
| 12/21/2006 | US20060287378 Novel pyrroles and imidazoles |
| 12/21/2006 | US20060287370 Isoindolinone kinase inhibitors |
| 12/21/2006 | US20060287369 Diarylmethyl and related compounds |
| 12/21/2006 | US20060287348 N-(pyridin-2-ylmethyl)-4-methyl-3-oxo-4-aza-5 alpha -androst-1-en-17 beta -acetamide; enhancement of weakened muscle tone; osteoporosis, bone disorders; ; periodontal disease, frailty, aging skin, male hypogonadism, postmenopausal symptoms, inflammatory arthritis, cachexia, Alzheimer's disease |
| 12/21/2006 | US20060287328 Fungicides; pest control; 1-Dimethyl-3-(2'-nitro)phenyl-silacyclohexene-2; Trans-1-(2'trifluoromethylsulfonyloxy-phenyl)-2-trimethylsilyl-cyclopropane |
| 12/21/2006 | US20060287326 17-Acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 12/21/2006 | US20060287315 Pyrazinedicarboxamides and their use |
| 12/21/2006 | US20060287313 Isoquinoline compounds and methods of use thereof |
| 12/21/2006 | US20060287312 Tetracyclic amino and carboxamido compounds and methods of use thereof |
| 12/21/2006 | US20060287311 Tetracyclic Sulfonamide Compounds and methods of use thereof |
| 12/21/2006 | US20060287308 3-Aminoquinazolin-2,4-dione antibacterial agents |
| 12/21/2006 | US20060287306 Compounds to treat alzheimer's disease |
| 12/21/2006 | US20060287304 Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient |
| 12/21/2006 | US20060287303 Modulators of muscarinic receptors |
| 12/21/2006 | US20060287302 Mitotic kinesin inhibitors |
| 12/21/2006 | US20060287298 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 12/21/2006 | US20060287295 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide |
| 12/21/2006 | US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 12/21/2006 | US20060287291 such as 2-Methoxy-5-methyl-N-[7-(piperazin-1-ylcarbonyl)-1-benzofuran-5-yl]benzenesulfonamide for treating disorders related to 5-HT6 receptor related disorders such as obesity, type II diabetes, anxiety, depression, panic attacks, memory/sleep/cognitive disorders, epilepsy, obsessive compulsive disorder |
| 12/21/2006 | US20060287290 Azabicyclic compounds are central nervous system active agents |
| 12/21/2006 | DE102005029382B3 New alkoxymethylyl substituted benzoic acid derivatives are peroxisome proliferation activated receptor agonists used for treating and/or preventing e.g. diabetes mellitus, dyslipidemia and disturbances in fatty acid metabolism |
| 12/21/2006 | CA2611711A1 Piperazine-piperidine antagonists and agonists of the 5-ht1a receptor |
| 12/21/2006 | CA2611562A1 Trisubstituted amines as phosphodiesterase 4 inhibitors |
| 12/21/2006 | CA2611443A1 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 12/21/2006 | CA2611378A1 Aminoquinoline and aminoquinazoline kinase modulators |
| 12/21/2006 | CA2611242A1 Alkylquinoline and alkylquinazoline kinase modulators |
| 12/21/2006 | CA2611219A1 Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators and related methods of synthesis |
| 12/21/2006 | CA2610900A1 Compounds for the treatment of multi-drug resistant bacterial infections |
| 12/21/2006 | CA2610884A1 Inhibitors of checkpoint kinases |
| 12/21/2006 | CA2610588A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/21/2006 | CA2610429A1 Trombin inhibiting 2,4-dioxo-3,4-dihydropyrimidine derivatives |
| 12/21/2006 | CA2610188A1 Oxadiazole derivatives as dgat inhibitors |
| 12/21/2006 | CA2607054A1 1, 2-di(cyclic group)substituted benzene derivative |
| 12/20/2006 | EP1734040A1 Substituted quinazoline or pyridopyrimidine derivative |
| 12/20/2006 | EP1732922A1 Methods for minimizing thioamide impurities |
| 12/20/2006 | EP1732921A1 Thioamide derivatives as progesterone receptor modulators |
| 12/20/2006 | EP1732920A2 Thiophene derivatives as chk 1 inhibitors |
| 12/20/2006 | EP1732919A1 Substituted thiophene derivatives as anti-cancer agents |
| 12/20/2006 | EP1732896A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp) |
| 12/20/2006 | EP1732892A1 Tetrahydrocarbazoles and derivatives |
| 12/20/2006 | EP1732884A1 Sulphonamide derivatives |
| 12/20/2006 | EP1732566A2 6-azaindole compound |
| 12/20/2006 | EP1732564A1 Biaryl substituted pyrazinones as sodium channel blockers |
| 12/20/2006 | EP1732385A1 Use of (3-(1-(3-phenyl-propenyl)-piperidin-4-yl)-2,3-dihydro-indol-1-yl)-(pyridin-4-yl)-methanone derivatives and related compounds as insecticides |